Skip to main navigation Skip to search Skip to main content

A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

Translated title of the contribution: A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity
  • D.A. Rider
  • , C.E.G. Havenith
  • , R. de Ridder
  • , J. Schuurman
  • , C. Favre
  • , J.C. Cooper
  • , S.M. Walker
  • , O. Baadsgaard
  • , S. Marschner
  • , J.G.J. van de Winkel
  • , J. Cambier
  • , P.W.H.I. Parren
  • , D.R. Alexander

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionA human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity
Original languageUndefined/Unknown
Pages (from-to)9945-9953
Number of pages9
JournalCancer Research
Volume67
Publication statusPublished - 2007

Cite this